Lupin Ltd.
SET SMS ALERT| 5-Day | 530,812 |
| 10-Day | 336,185 |
| 30-Day | 192,487 |
| 5-Day | 530,812 |
| 10-Day | 336,185 |
| 30-Day | 192,487 |
Depth
Market Depth (18 Jun 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 268 | 907.00 | 908.30 | 50 |
| 3 | 906.55 | 908.35 | 30 |
| 600 | 906.25 | 908.90 | 114 |
| 5 | 906.10 | 909.65 | 100 |
| 66 | 906.00 | 909.70 | 40 |
| 6761 | Total | 12.15 K | Total |
Buy Qty
6761
Sell QTY
12.15 K
| 5-Day | 6,762,592 |
| 10-Day | 4,397,142 |
| 30-Day | 2,635,834 |
| 5-Day | 6,762,592 |
| 10-Day | 4,397,142 |
| 30-Day | 2,635,834 |
- Quote
- CHARTS
- NEWS
- COMMENTS12 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Lupin
Sentimeter
75% of moneycontrol users recommend buying Lupin.
What's your call on Lupin today?
Read 12 investor views
Top Trading Ideas
15 June 2018
buy SunPharma Jun Fut |
Entry Price (Rs) 557.30 |
Exit Price (Rs) 572.85 |
Gain (Rs) 16.00 |
| Days | BSE | NSE |
| 30 | 779.62 | 780.16 |
| 50 | 786.94 | 787.33 |
| 150 | 820.22 | 820.41 |
| 200 | 867.72 | 867.91 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Lupin
| Standalone | Mar'18 | Dec'17 | Sep'17 | Jun'17 |
| Net Sales | 2,425.94 | 2,462.11 | 2,528.11 | 2,437.74 |
| Other Income | 53.23 | 23.98 | 74.33 | 27.89 |
| PBDIT | 454.45 | 498.15 | 541.51 | 543.44 |
| Net Profit | 292.46 | 309.18 | 388.90 | 354.12 |
(In Rs Cr)
| Total Share Capital | 90.32 |
| Net Worth | 14,780.24 |
| Total Debt | 588.51 |
| Net Block | 3,012.52 |
| Investments | 6,913.92 |
| Total Assets | 15,368.75 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 571.05 | 2.04 | 608.55 | 433.15 | 137,013.43 |
| Cipla | 612.00 | 4.09 | 663.00 | 508.10 | 49,277.70 |
| Piramal Enter | 2500.15 | 3.08 | 3009.29 | 2279.05 | 45,150.84 |
| Lupin | 910.40 | 1.30 | 1194.00 | 723.55 | 41,159.46 |
| Cadila Health | 398.50 | -0.18 | 554.20 | 341.65 | 40,796.14 |
| More » | |||||
| Mar' 18 | Dec' 17 | Jun' 17 | Mar' 17 | |
| Promoter | 47.01 | 47.02 | 46.70 | 46.69 |
| Public (FII + DII) | 52.99 | 52.98 | 53.30 | 53.31 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| SBI - ETF Nifty 50 | 1,871,952 |
| Franklin India Equity Fund (G) | 1,849,253 |
| ICICI Prudential Balanced Advantage Fund (G) | 1,579,916 |
| Franklin India Bluechip Fund (G) | 1,529,527 |
Meghmani Organics Recommended on Aug 27th 2017
Recommended price 73.00 | Peak from reco 129.40 78.11%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Lupin
Lupin is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 41,159.46 crore.
The company management includes Desh Bandhu Gupta - Chairman, Kamal K Sharma - Vice Chairman, Nilesh Gupta - Managing Director, Manju D Gupta - Executive Director, Ramesh Swaminathan - Executive Director, Vijay Kelkar - Independent Director, R A Shah - Independent Director, Richard Zahn - Independent Director, K U Mada - Independent Director, Dileep C Choksi - Independent Director, Jean-Luc Belingard - Independent Director, Vinita Gupta - Chief Executive Officer.
It is listed on the BSE with a BSE Code of 500257 and the NSE with an NSE Code of LUPIN.
Its Registered office is at Kalpataru Inspire, 3rd Floor,,Off. Western Express Highway, Mumbai,Maharashtra - 400055.
Their Registrars are Link Intime India Pvt. Ltd.
